{
    "nctId": "NCT00735215",
    "briefTitle": "Faslodex Registry: Fulvestrant in Current Clinical Practice",
    "officialTitle": "Faslodex Registry: a Belgian Observational Study to Evaluate the Use of Fulvestrant in Current Clinical Practice",
    "overallStatus": "COMPLETED",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "to collect real life data on the use of fulvestrant in clinical practice in Belgium. Previous therapies (hormonal and chemo) for breast cancer and for advanced breast cancer will be documented for each patient.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Postmenopausal women with hormone receptor-positive locally advanced or metastatic breast cancer\n\nExclusion Criteria:",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}